MedPath

Atreleuton

Generic Name
Atreleuton
Drug Type
Small Molecule
Chemical Formula
C16H15FN2O2S
CAS Number
154355-76-7
Unique Ingredient Identifier
U301T88E1M

Overview

Atreleuton has been used in trials studying the treatment of Atherosclerosis and Coronary Artery Disease.

Background

Atreleuton has been used in trials studying the treatment of Atherosclerosis and Coronary Artery Disease.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 2 Study in Vascular Inflammation on Patients After an Acute Coronary Syndrome Event
Phase 2
Completed
Posted: 2007/11/01
Sponsor:
Tallikut Pharmaceuti...
ID:NCT00552188
Study Effect of VIA-2291 on Vascular Inflammation
Phase 2
Completed
Posted: 2006/08/01
Sponsor:
Tallikut Pharmaceuti...
ID:NCT00358826
Study Effect of VIA-2291 on Atherosclerotic Vascular Inflammation in Patients Undergoing Elective Carotid Endarterectomy
Phase 2
Completed
Posted: 2006/07/14
Sponsor:
Tallikut Pharmaceuti...
ID:NCT00352417

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy